dbt Core
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
A side-by-side editorial comparison of NocoDB and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
Interfaces gets the permissions layer it needed, one release after launching.
NocoDB ships monthly, and the last two releases are a launch and its follow-through. 2026.08.0 introduced Interfaces, custom app surfaces built over a base; 2026.08.1 gives that layer what it was missing — per-dashboard visibility and editing permissions, field edit permissions enforced on interface pages, team-granted access, and page reordering. Alongside it the grid gains realtime presence with per-collaborator colours and jump-to-cursor, folders for grouping tables and views, up to three frozen fields, and nested records in List View.
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
NocoDB ships monthly, and the last two releases are a launch and its follow-through. 2026.08.0 introduced Interfaces, custom app surfaces built over a base; 2026.08.1 gives that layer what it was missing — per-dashboard visibility and editing permissions, field edit permissions enforced on interface pages, team-granted access, and page reordering. Alongside it the grid gains realtime presence with per-collaborator colours and jump-to-cursor, folders for grouping tables and views, up to three frozen fields, and nested records in List View.
The pattern is consistent: NocoDB launches a surface, then spends the next release making it governable and usable at team scale. Presence and folders are collaboration parity rather than new direction — the directional bet was Interfaces, and this release is that bet being made safe for the eighty people who only need to approve something. The permission system is now the same one across tables, fields, dashboards, and interface pages, which is the consolidation that makes the app layer sellable.
Write-back actions and embedding are the remaining pieces app builders expect from Interfaces, and the availability tables in each release suggest they land on the paid tier.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either NocoDB or pharmaversesdtm.
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.
Holistics keeps fencing in the AI layer it spent the summer building.
Dovetail spent July opening doors to other tools and August making its own rooms easier to enter.
The 0.0.x train stops at CRAN: tulpa's engine ships to the ecosystem it already anchors.
AgencyAI got skills three weeks ago; everything since has been making them routine.
See all NocoDB alternatives → · See all pharmaversesdtm alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. NocoDB is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. NocoDB is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top NocoDB alternatives in Analytics are ranked by recent ship velocity. Browse the "NocoDB alternatives" section above for the current picks, or visit /alternatives/nocodb for the full list with editorial commentary on each.
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.